Model Number 8637-20 |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Low Blood Pressure/ Hypotension (1914); Overdose (1988); Respiratory Distress (2045); Dizziness (2194); Complaint, Ill-Defined (2331); Reaction (2414); Ambulation Difficulties (2544)
|
Event Date 09/22/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
On 2018-july-06, information was received from an healthcare professional (hcp) via a manufacturer representative (rep) regarding a patient receiving gablofen (2,000 mcg/ml, 177 mcg/day) via an implantable pump for intractable spasticity and post spinal cord injury.Since implant on (b)(6) 2017, the hcp has been titrating the patient's daily dose.The patient reported that each time there was a dose increase, their legs felt heavy and they were not able to do as much daily walking as normal.The hcp began troubleshooting the system on (b)(6) 2018.There were no reported environmental, external, or patient factors that may have led or contributed to the issue.X-rays appeared to be normal from "what can be visualized".Side-port aspiration was completed; 1 cc was aspirated from the catheter and priming bolus of the catheter only was programmed.It was stated, "after these procedures today, patient began to complain of dizziness, became hypotensive and went into respiratory distress.The patient was taken to the hospital where they were currently intubated and receiving medical assistance (respiratory support).The rep reviewed the programming strip with the hcp to ensure that only the catheter was primed during the side-port aspiration and no issues were seen on the programming strip.The issue was not resolved at the time of this report.No surgical intervention occurred nor was planned.The patient's status was alive - with injury.Note; the report title states, "side-port aspiration/possible overdose/jf" with no further mention of the term 'overdose' anywhere else in the report.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
On (b)(6) 2018, additional information was received from the healthcare professional (hcp) via the manufacturer representative (rep).The hcp went to the hospital to see the patient over the weekend and that they were doing better.The patient was extubated and medically stable.The hcp turned the patient from minimum rate back to their previous.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Corrected information.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
The patient codes have been updated to include (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
On 2018-aug-10, additional information was received from the healthcare professional (hcp).They reported overdose was not confirmed.The patient experienced an adverse effect of intrathecal baclofen medication.The cause of the patient's symptoms "adverse effect of intrathecal baclofen after reprogramming".The cause of the patient's heavy feeling legs and difficulty walking was "likely updated to increase intrathecal baclofen in system".The patient status was stable and they had recovered.
|
|
Search Alerts/Recalls
|